Skip to main content

Table 1 : Characteristics of the studied population

From: Venoarterial extracorporeal membrane oxygenation induces early immune alterations

Variables VA–ECMO
n = 9
Control
n = 9
p
Gender, n (%)    0.99
 Male 6 (67) 7 (77)  
 Female 3 (33) 2 (23)  
Age, years, median (IQR) 59 (57–63) 56 (47–68) 0.87
BMI, kg/m2, median (IQR) 26 (24–29) 28 (27–35) 0.19
Diabetes, n (%) 2 (22) 2 (22) 0.99
Cancer, n (%) 1 (11) 0 0.99
Chronic kidney disease, n (%) 0 1 (11) 0.99
Chronic heart failure, n (%) 2 (22) 4 (44) 0.62
Tobacco use, n (%) 4 (44) 1 (11) 0.29
Causes of cardiogenic shock    0.22
 Acute coronary syndrome 7 (78) 3 (33)  
 Acute decompensated heart failure 1 (11) 4 (44)  
 Myocarditis 1 (11) 1 (11)  
 Acute stress-induced cardiomyopathy 0 (0) 1 (11)  
Highest blood lactate level, median (IQR) 2.7 (2.3–4.2) 3.6 (2,6–6.8) 0.31
SAPS II, median (IQR) 45 (36–54) 41 (34–44) 0.39
SOFA baseline, median (IQR) 9 (7–13) 7 (3–9) 0.16
SOFA day 1, median (IQR) 9 (8–13) 9 (7–9) 0.32
Mechanical ventilation duration, days, median (IQR) 17 (9–21) 0 (0–14) 0.01
Vasopressor use duration, days, median (IQR) 15.5 (9.8–19.5) 6 (3–8) 0.049
Length of hospital stay, days, median (IQR) 17 (14–21) 0 (0–14) 0.001
Nosocomial infection, n (%) 5 (56) 1 (11) 0.13
7-day mortality, n (%) 1 (11) 1 (8) 0.99
30-day mortality, n (%) 5 (56) 4 (30) 0.99
90-day mortality, n (%) 5 (56) 6 (67) 0.99
  1. VA-ECMO, venoarterial extracorporeal membrane oxygenation; BMI, Body mass index; ICU, Intensive care unit; SAPS II, Simplified acute physiology score; SOFA, Sequential organ failure assessment